3 Foundations of best practice
4 COVID-19 as stimulus for innovation
5 Adapting and evolving therapeutic approach
6 Age and comorbidities as risk factors
7 Over-capacity ICU
8 Adapting the ER for COVID-19
9 Training personnel for COVID-19
10 Psychological support, healthcare heroes, and COVID fatigue
11 Increased oxygen requirement
12–13 Milan’s multi-disciplinary unit
14 Standardizing respiratory support measures
15 Nutrition, sedation, and life support
16 CPAP successes and failures
17 Prone and lateral positioning of patients on CPAP
18 Different COVID-19 phenotypes?
19 Thromboembolism risk score, age, and comorbidities
20 Cardiorespiratory considerations: hypertension, echocardiography
21 Thrombosis and thromboembolism
22 Hypertension and anti-hyperintensive drugs
23 Inflammation and steroid therapies
24 Lung transplantation
25 Possible genetic risk factors
26 Dr. Blasi’s summary
27–28 Hypertension and COVID-19 pneumonia
29–30 Smoking, COPD, bronchiectasis, and cystic fibrosis
31–35 Pathophysiology of COVID-19; treatment with steroids
36–39 Lung transplantation in the Time of COVID
40–41 “COVID fatigue”
44–45 Thanks and sign-off
The author(s) received no specific funding for this work.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Ramirez, Julio A. MD and Blasi, Francesco MD, PhD
"International Respiratory Infections Society COVID Research Conversations: Podcast 1 with Dr. Francesco Blasi,"
The University of Louisville Journal of Respiratory Infections: Vol. 5
, Article 3.
Available at: https://ir.library.louisville.edu/jri/vol5/iss1/3